Reported May 29, 2013 · Terminated
Levoxyl (levothyroxine sodium) tablets, USP, 200 mcg, packaged in a) 100-count bottles (NDC 60793-860-01) and b)…
King Legacy, a wholly owned subsidiary of Pfizer
Moderate riskThis product could cause temporary or reversible health problems — stop using it.What you should do
Stop using the affected lot and contact the recalling firm for the return or refund process. Check the FDA enforcement report for lot-level detail.
Firm contact: King Legacy, a wholly owned subsidiary of Pfizer · 501 5th Street · Bristol, TN · 37620-2304
Is this the product you have?
- Levoxyl (levothyroxine sodium) tablets, USP, 200 mcg, packaged in a) 100-count bottles (NDC 60793-860-01) and b) 1000-count bottles (NDC 60793-860-10), Rx only
- Manufactured and Distributed byKing Pharmaceuticals, Inc., Bristol, TN 37620
- Lot codes and dates
Lot # a) 64301Exp. 4/13 and 65628Exp. 7/13b) 64300Exp. 4/13 and 65765Exp. 7/13
- Amount recalled
- 33,227 bottles
This recall covers 11 products
The agency filed one notice per product. You are reading one of them; the other 10 are below.
Where it was sold
- Nationwide
- PR
Why it was recalled
Subpotent Drug: The products were below specification for potency at the expiry stability point.
This product could cause temporary or reversible health problems — stop using it.
Want the full recall guide?
The guide adds the identifying codes laid out for scanning, symptoms to watch for, a timeline, and news coverage of this recall.
Free recall alerts
Get alerted about new King Legacy, a wholly owned subsidiary recalls
One email when a matching recall is published. No account, no cost, unsubscribe in one click.
We email you about recalls and nothing else. Every send has a one-click unsubscribe, and you can change your preferences any time without an account.